Sort
50,496 grants matching “lung cancer”
Inhaled DNA demethylating therapy for lung cancer and bronchial premalignancy
$483,713Roman Perez-Soler · Albert Einstein College Of Medicine · R01 · FY2014 · CA
Project 2: Combined CAR-T cell therapy
$483,710Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P50 · FY2023 · CA
Neutrophil Plasticity and H. pylori Pathogenesis
$483,705Lee-Ann H. Allen · University Of Missouri-Columbia · R01 · FY2020 · AI
Benefits and Harms of Lung Cancer Screening in HIV Infection
$483,682Kristina Anne Crothers · University Of Washington · R01 · FY2014 · CA
Training in Comparative Lung Biology and Medicine
$483,657Nicholas J Kenyon · University Of California At Davis · T32 · FY2020 · HL
Coordinating Center: Molecular and Cellular Findings of Screen-Detected Lesions
$483,640Christopher I. Amos · Dartmouth College · U01 · FY2015 · CA
Nitric Oxide as a Modifier of Oxidative Stress
$483,577David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2020 · CA
Novel roles of STAT2 and IFN-I in tumorigenesis and responses to therapy
$483,558George Robert Stark · Cleveland Clinic Lerner Com-Cwru · P01 · FY2022 · CA
Novel roles of STAT2 and IFN-I in tumorigenesis and responses to therapy
$483,558George Robert Stark · Cleveland Clinic Lerner Com-Cwru · P01 · FY2025 · CA
Role of ACER2 in cancer chemoresistance and metastasis
$483,556Cungui Mao · State University New York Stony Brook · R01 · FY2024 · CA
Defining and characterizing microenvironmental drivers of disseminated tumor cell dormancy in brain
$483,488Cyrus M Ghajar · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA
Estrogen Suppression as a Strategy to Enhance Immunotherapy Efficacy in EGFR-Mutated Non-Small Cell Lung Cancer
$483,395Joseph Nicholas Bodor · Research Inst Of Fox Chase Can Ctr · R21 · FY2024 · CA
Optimizing Tobacco Treatment Delivery for People Living with HIV
$483,380Alana Rojewski · Medical University Of South Carolina · R01 · FY2023 · CA
FGF9 REGULATION OF LUNG DEVELOPMENT AND PATHOGENESIS OF PLEUROPULMONARY BLASTOMA
$483,361David M Ornitz · Washington University · R01 · FY2013 · HL
Hermansky Pudlak Syndrome & melanosome formation
$483,315Michael S Marks · University Of Pennsylvania · R01 · FY2012 · EY
Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation
$483,245Muneeb Ahmed · Beth Israel Deaconess Medical Center · R01 · FY2019 · CA
Effects of FLASH Radiation on Cancer and the Immune Response
$483,153Edgar G. Engleman · Stanford University · R01 · FY2023 · CA
Aberrant megakaryopoiesis in the myeloproliferative neoplasms.
$483,125John D Crispino · Northwestern University At Chicago · R01 · FY2017 · HL
Metabolic activation of nitroarenes and Nrf2-Keap1
$483,121Trevor M. Penning · University Of Pennsylvania · R01 · FY2019 · ES
UDP-GLUCURONOSYLTRANSFERASE GENOTYPE AND CANCER RISK
$483,110Philip Lazarus · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2008 · DE
Causes and Consequences of Acid pH in Tumors
$483,104Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2010 · CA
Matrix density promotes pro-tumorigenic hormone actions in breast cancer
$483,032Linda A. Schuler · University Of Wisconsin-Madison · R01 · FY2021 · CA
MARIJUANA USE AND THE RISKS OF LUNG AND OTHER CANCERS
$482,973University Of California Los Angeles · R01 · FY2001 · DA
PROMISE Trial: Substudy to Assess for Effective Dose of Radiation
$482,938Andrew Einstein · Columbia University Health Sciences · R01 · FY2012 · HL
Comparative modeling of sarcoma microenvironments for the discovery of biomarkers and tumor vulnerabilities
$482,921Jlenia Guarnerio · Cedars-Sinai Medical Center · R01 · FY2022 · CA